Dimethyltryptamine (DMT): Subjective effects and patterns of use among Australian recreational users

Drug and Alcohol Dependence

Volumn 111, Issue 1-2, 2010, Pages 30-37

  Cakic, Vince ^a   Potkonyak, Jacob ^b   Marshall, Alex ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b MACQUARIE UNIVERSITY   (Australia)

Author keywords

Ayahuasca; Dimethyltryptamine; DMT; Hallucinogens; Psychedelics

Indexed keywords

N,N DIMETHYLTRYPTAMINE;

ADULT; AGED; ARTICLE; AUSTRALIA; CONTROLLED STUDY; DRUG EFFICACY; DRUG INDICATION; DRUG UTILIZATION; FEMALE; HEALTH BEHAVIOR; HEALTH BELIEF; HUMAN; MALE; ONLINE SYSTEM; PRIORITY JOURNAL; QUESTIONNAIRE; RECREATION; RELIGION; RITUAL; SMOKING;

ADMINISTRATION, INHALATION; ADOLESCENT; ADULT; AGED; ATTITUDE TO HEALTH; AUSTRALIA; FEMALE; HALLUCINOGENS; HUMANS; MALE; MIDDLE AGED; N,N-DIMETHYLTRYPTAMINE; QUESTIONNAIRES; SMOKING; STATISTICS, NONPARAMETRIC; SUBSTANCE-RELATED DISORDERS;

BANISTERIOPSIS CAAPI;

EID: 77956190837     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2010.03.015     Document Type: Article

References (58)

1. Andrew+s J.A., Tildesley E., Hops H., Li F. The influence of peers on young adult substance use. Health Psychol. 2002, 21:349-357.
2. Barker S.A., Monti J.A., Christian S.T. N,N-dimethyltryptamine: an endogenous hallucinogen. Int. Rev. Neurobiol. 1981, 22:83-110.
3. Biernacki P., Waldorf D. Snowball sampling: problems and techniques of chain referral sampling. Sociol. Methods Res. 1981, 10:141-163.
4. Boyer E.W., Shannon M., Hibberd P.L. The Internet and psychoactive substance use among innovative drug users. Pediatrics 2005, 115:302-305.
5. Bullis R.K. The " vine of the soul" vs. the Controlled Substances Act: implications of the Hoasca case. J. Pschoactive Drugs 2008, 40:193-199.
6. Bunzow J.R., Sonders M.S., Arttmangkul S., Harrison L.M., Zhang G., Quigley D.I., Darland T., Suchland K.L., Pasumamula S., Kennedy J.L., Olson S.B., Magenis R.E., Amara S.G., Grandy D.K. Amphetamine, 3,4-methylenedioxymethamphetamine, lysergic acid diethylamide, and metabolites of the catecholamine neurotransmitters are agonists of a rat trace amine receptor. Mol. Pharmacol. 2001, 60:1181-1188.
7. Callaway J.C., Grob C.S. Ayahuasca preparations and serotonin reuptake inhibitors: a potential combination for severe adverse interactions. J. Psychoactive Drugs 1998, 30:367-369.
8. Callaway J.C., McKenna D.J., Grob C.S., Brito G.S., Raymon L.P., Poland R.E., Andrade E.N., Andrade E.O., Mash D.C. Pharmacokinetics of Hoasca alkaloids in healthy humans. J. Ethnopharmacol. 1999, 65:243-256.
9. Cox, N., 2009. Police seize killer new drug. (accessed 12.02.10). http://www.theaustralian.news.com.au/story/0,24751058-5006789,00.html.
10. Da Silveira D.X., Grob C.S., Dobkin de Rios M., Lopez E., Alonson L.K., Tacla C., Doering-Silveira E. Ayahuasca in adolescence: a preliminary psychiatric assessment. J. Psychoactive Drugs 2005, 37:129-133.
11. Dalgarno P. Buying ayahuasca and other entheogens online: a word of caution. Addict. Res. Theory 2008, 16:1-4.
12. De Conceicao, P., 2009. The DMT molecule: A tryst with spirits, elves and aliens. (accessed 15.05.10). http://www.examiner.com/x-17195-LA-Esoteric-History-Examiner~y2009m8d6-The-DMT-molecule-A-tryst-with-spirits-elves-and-aliens.
13. Dobkin de Rios M. Visionary Vine: Hallucinogenic Healing in the Peruvian Amazon 1972, Chandler Publishing, San Francisco.
14. Doering-Silveira E., Grob C.S., Dobkin de Rios M., Lopez E., Alonso L.K., Tacla C., Da Silveira D.X. Report on psychoactive drug use among adolescents using ayahuasca within a religious context. J. Psychoactive Drugs 2005, 37:141-144.
15. Doering-Silveira E., Lopez E., Grob C.S., Dobkin de Rios M., Alonson L.K., Tacla C., Shirakawa I., Bertolucci P.H., Da Silveira D.X. Ayahuasca in adolescence: a neuropsychological assessment. J. Psychoactive Drugs 2005, 37:123-128.
16. Doherty M.C., Garfein R.S., Monterroso E., Latkin C., Vlahov D. Gender differences in the initiation of injection drug use among young adults. J. Urban Health 2000, 77:396-414.
17. Faillace L.A., Szára S. Hallucinogenic drugs: influence of mental set and setting. Dis. Nerv. Syst. 1968, 29:124-126.
18. Fitzgerald J.S., Sioumis A.A. Alkaloids of the Australian Leguminosae: V. The occurrence of methylated tryptamines in Acacia maidenii. Aust. J. Chem. 1965, 18:433-434.
19. Fontanilla D., Johannessen M., Hajipour A.R., Cozzi N.V., Jackson M.B., Ruoho A.E. The hallucinogen N,N-dimethyltryptamine (DMT) is an endogenous sigma-1 receptor regulator. Science 2009, 323:934-937.
20. Forsyth A.J.M. Places and patterns of drug use in the Scottish dance scene. Addiction 1996, 91:511-521.
21. Gable R.S. Risk assessment of ritual use of oral dimethyltryptamine (DMT) and harmala alkaloids. Addiction 2007, 102:24-34.
22. Gonzalez D., Riba J., Bouso J.C., Gomez-Jarabo G., Barbanoj M.J. Pattern of use and subjective effects of Salvia divinorum among recreational users. Drug Alcohol Depend. 2006, 85:157-162.
23. Greenhouse, L., 2006. Sect allowed to import its hallucinogenic tea. (accessed 15.05.10). http://www.nytimes.com/2006/02/22/politics/22scotus.html.
24. Griffiths R.R., Richards W.A., Johnson M.W., McCann U.D., Jesse R. Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later. J. Psychopharmacol. 2008, 22:621-632.
25. Griffiths R.R., Richards W.A., McCann U., Jesse R. Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance. Psychopharmacology 2006, 187:268-283.
26. Grigoriadis, V., 2006. Daniel Pinchbeck and the new psychedelic elite. (accessed 12.02.10). http://www.rollingstone.com/politics/story/11217201/daniel_pinchbeck_and_the_new_psychedelic_elite.
27. Grob C.S., McKenna D.J., Callaway J.C., Brito G.S., Neves E.S., Oberlaender G., Saide O.L., Labigalini E., Tacla C., Miranda C.T., Strassman R.J., Boone K.B. Human psychopharmacology of hoasca, a plant hallucinogen used in ritual context in Brazil. J. Nerv. Ment. Dis. 1996, 184:86-94.
28. Grof S. LSD Psychotherapy 2008, MAPS, Ben Lonmond.
29. Halpern J.H., Pope H.G. Hallucinogens on the internet: a vast new source of underground drug information. Am. J. Psychiatry 2001, 158:481-483.
30. Halpern J.H., Sherwood A.R., Passie T., Blackwell K.C., Ruttenber A.J. Evidence of health and safety in American members of a religion who use a hallucinogenic sacrament. Med. Sci. Monit. 2008, 14:S15-S22.
31. Hofmann A. LSD: My Problem Child 2005, MAPS, Sarasota, FL.
32. Kandel D.B., Kessler R.C., Margulies R.Z. Antecedents of adolescent initiation into stages of drug use: a developmental analysis. J. Youth Adolesc. 1978, 7:13-40.
33. Lange J.E., Reed M.B., Croff J.M.K., Clapp J.D. College student use of Salvia divinorum. Drug Alcohol Depend. 2008, 94:263-266.
34. Luckman S. Going bush and finding one's 'tribe': raving, escape and the bush doof. Continuum: J. Media Cult. Stud. 2003, 17:315-330.
35. MacRae E. Santo Daime and Santa Maria-the licit ritual use of ayahuasca and the illicit use of cannabis in a Brazilian Amazonian religion. Int. J. Drug Policy 1998, 9:325-338.
36. McKenna D.J. Clinical investigations of the therapeutic potential of ayahuasca: rationale and regulatory challenges. Pharmacol. Ther. 2004, 102:111-129.
37. McKenna D.J. Ayahuasca: an ethnopharmacologic history. Sacred Vine of Spirits: Ayahuasca 2006, Park Street Press, Rochester, Vermont. R. Metzner (Ed.).
38. Otis, J., 2009. Down the Amazon in search of ayahuasca. (accessed 15.05.10). http://www.time.com/time/world/article/0,8599,1889631,00.html.
39. Ott J. Pharmacoetheon: Entheogenic Drugs, Their Plant Sources and History 1996, Natural Products Co., Kennewick, WA.
40. Pomilio A.B., Vitale A.A., Ciprian-Ollivier J., Cetkovich-Bakmas M., Gómez R., Vazquez G. Ayahoasca: an experimental psychosis that mirrors the transmethylation hypothesis of schizophrenia. J. Ethnopharmacol. 1999, 65:29-51.
41. Room R. Stigma, social inequality and alcohol and drug use. Drug Alcohol Rev. 2005, 24:143-155.
42. Rothlin E. Pharmacology of lysergic acid diethylamide (LSD) and some of its related compounds. Psychotropic Drugs 1957, 36-47. Elsevier, New York. S. Garattini, V. Ghetti (Eds.).
43. Rouvelli B., Vaughan G.N. Alkaloids of Acacia I. Nb-Nb-dimethyltryptamine in Acacia phlebophylla. Aust. J. Chem. 1967, 20:1299-1300.
44. Shanon B. The Antipodes of the Mind: Charting the Phenomenology of the Ayahuasca Experience 2002, Oxford University Press, New York.
45. Shulgin A., Shulgin A. Phenethylamines and I have Known and Loved: A Chemical Love Story 1991, Transform Press, Berkley, CA.
46. Shulgin A., Shulgin A. Tryptamines I have Known and Loved: The Continuation 1997, Transform Press, Berkley, CA.
47. 2C receptors. Pharmacol. Biochem. Behav. 1998, 61:323-330.
48. Strassman R.J. DMT: The Spirit Molecule 2001, Park Street Press, Rochester, Vermont.
49. Swift W., Copeland J., Hall W. Choosing a diagnostic cut-off for cannabis dependence. Addiction 1998, 93:1681-1692.
50. Szára S. Dimethyltryptamin: its metabolism in man; the relation of its psychotic effect to the serotonin metabolism. Cell. Mol. Life Sci. 1956, 12:441-442.
51. Thompson S.K., Collins L.M. Adaptive sampling in research on risk-related behaviors. Drug Alcohol Depend. 2002, 68:S57-67.
52. Tramacchi D. Field tripping: psychedelic communitas and ritual in the Australian bush. J. Contemp Rel. 2000, 15:201-213.
53. Tramacchi, D., 2006. Vapours and visions: Religious dimensions of DMT use. School of History, Philosophy, Religion and Classics. University of Queensland, Brisbane.
54. Trichter S., Klimo J., Krippner S. Changes in spirituality among ayahuasca ceremony novice participants. J. Psychoactive Drugs 2009, 41:121-134.
55. Tupper K.W. Ayahuasca healing beyond the Amazon: the globalization of a traditional indigenous entheogenic practice. Global Netw. 2009, 9:117-136.
56. Tupper K.W. The globalization of ayahuasca: harm reduction or benefit maximisation?. Int. J. Drug Policy 2008, 19:297-303.
57. Turner D.M. The Essential Psychedelic Handbook 1994, Panther Press, San Francisco.
58. Wilkinson D.A., Leigh G.M., Cordingley J., Martin G.W., Lei H. Dimensions of multuple drug use and a typology of drug users. Br. J. Addict. 1987, 82:259-273.